o(6)-benzylguanine has been researched along with gemcitabine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bobustuc, GC; Frick, J; Konduri, SD; Patel, A; Srivenugopal, KS; Thompson, M; Weese, J | 1 |
1 other study(ies) available for o(6)-benzylguanine and gemcitabine
Article | Year |
---|---|
MGMT inhibition suppresses survivin expression in pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Deoxycytidine; DNA Modification Methylases; DNA Repair Enzymes; Down-Regulation; Gemcitabine; Gene Expression Regulation, Neoplastic; Guanine; Humans; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Random Allocation; RNA Interference; Survivin; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2015 |